Tech Company Financing Transactions
Euthymics Bioscience Funding Round
On 3/31/2012, Euthymics Bioscience raised $1.9 million in funding from GBS Venture Partners, Hambrecht & Quist Capital Management and Novartis Venture Fund.
Transaction Overview
GBS Venture Partners (Andrew Baker)
Hambrecht & Quist Capital Management (Frank Gentile)
Novartis Venture Fund (Campbell Murray)
Venture Investors (Paul Weiss)
Company Information
Cambridge, MA 02142
USA
Management Team
Browse more venture capital transactions:
Prev: 3/31/2012: Coherex Medical venture capital transaction
Next: 3/31/2012: M86 Security venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs